Fabio Bozzi

Fondazione IRCCS Istituto Nazionale dei Tumori — Italy

Medicine · Health Sciences

24h-index2.7kcitations87works7.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(38), Oral and Maxillofacial Pathology(11), Neuroblastoma Research and Treatments(11), Cancer-related molecular mechanisms research(9), Multiple Myeloma Research and Treatments(9)

Publications87 total

FASN for diffuse malignant peritoneal mesothelioma: a prognostic biomarker after CRS+HIPEC and a therapeutic target
2026Open Access
Detecting gene copy number alterations by Oncomine Comprehensive genomic profiling in a comparative study on FFPE tumor samples
Scientific Reports·2025· 5 citedOpen Access
Molecular profiling of pediatric and young adult colorectal cancer reveals a distinct genomic landscapes and potential therapeutic avenues
Scientific Reports·2024· 18 citedOpen Access
Periprosthetic effusions surrounding breast expander: a flow cytometric, immunohistochemical and molecular characterization
Tumori Journal·2023
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care
JCO Precision Oncology·2023· 22 citedOpen Access
Supplementary Materials and Methods, Tables S1-S2, and Figures S1-S6 from Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury
2023Open Access
Supplementary Materials and Methods, Tables S1-S2, and Figures S1-S6 from Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury
2023Open Access
Data from Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury
2023Open Access
Data from Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury
2023Open Access
Supplementary Figure 2 from Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics
2023Open Access
Supplementary Data from Functional Mapping of Receptor Tyrosine Kinases in Myxoid Liposarcoma
2023Open Access
Supplementary Figure 1 from Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics
2023Open Access
Data from Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics
2023Open Access
Supplementary Figure 1 from Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics
2023Open Access
Supplementary Figure 3 from Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics
2023Open Access
Supplementary Data from Functional Mapping of Receptor Tyrosine Kinases in Myxoid Liposarcoma
2023Open Access
Data from Functional Mapping of Receptor Tyrosine Kinases in Myxoid Liposarcoma
2023Open Access
Data from Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics
2023Open Access
Supplementary Figure 3 from Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics
2023Open Access
Data from Functional Mapping of Receptor Tyrosine Kinases in Myxoid Liposarcoma
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Silvana Pilotti(18), Elena Tamborini(16), Elena Conca(15), Tiziana Negri(14), Silvia Brich(13), Marco A. Pierotti(13), Silvia Stacchiotti(11), Anna Villa(10), Paolo Vezzoni(10), Alessandro Gronchi(10), Roberto Luksch(9), Federica Perrone(8), Paola Collini(7), Marta Podda(7), Andrea Ferrari(7), Gian Paolo Dagrada(7), Luigi D. Notarangelo(6), Paolo G. Casali(6), Annunziata Gloghini(6), Michela Casanova(6)